Interleukin Genetics To Offer Its Innovative Inflammation Management Program To Amway Employees
July 12, 2016 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., July 12, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on the genetics of chronic inflammation announced today that it has...
Interleukin Genetics Receives Notice of Allowance for United States Patent for PerioPredict® Genetic Risk Test
April 26, 2016 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., April 26, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on developing and marketing proprietary genetic tests for chronic...
Interleukin Genetics and Metagenics Enter Into Agreement to Incorporate PerioPredict® Into Metagenics’ Employee Benefit Plan
February 18, 2016 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., Feb. 18, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on developing and marketing proprietary genetic tests for chronic...